Ocean Optics Expands Flame Spectrometer Line with Versatile Miniature NIR Spectrometer
Flame-NIR puts the power of NIR analysis in a small-footprint instrument...
List view / Grid view
News
Phase 3 study of Blincyto in ALL meets primary endpoint
5 February 2016 | By Victoria White
Blincyto is a BiTE antibody construct that binds specifically to CD19 expressed on the surface of cells of B-lineage origin and CD3 expressed on the surface of T cells...
CPhI announces findings from its review of the US pharma manufacturing market
5 February 2016 | By Victoria White
Overall, the review demonstrates that US pharma industry and domestic manufacturers are showing increased confidence of renewed growth...
Continuous processing will require a change in mindset for controls and automation
4 February 2016 | By L.B. Bohle Maschinen + Verfahren GmbH
Continuous processing for secondary manufacturing in pharma is still one of the hottest topics currently discussed...
Orphan Drug Designation for acute spinal cord injury treatment
4 February 2016 | By Victoria White
AST-OPC1 has three potentially reparative functions that address the complex pathologies observed at the injury site of a spinal cord injury...
PDAC supports effectiveness of Brintellix in treating cognitive dysfunction in MDD
4 February 2016 | By Victoria White
The FDA Advisory Committee reviewed data from studies designed to assess the effect of Brintellix on cognitive dysfunction in adult patients with MDD...
Boehringer Ingelheim’s Spiriva Respimat available in the US
4 February 2016 | By Victoria White
Unlike other asthma daily maintenance treatments, Spiriva Respimat is from a new class of medications in asthma known as long-acting anticholinergics...
CHIRAL ART polysaccharide HPLC columns by YMC now with 3 µm!
To overcome the need of method developers for faster and high-resolution methods, YMC now offers all of its CHIRAL ART polysaccharide HPLC columns with a particle size of 3 µm.
FDA grants Fast Track Designation to TapImmune’s TPIV 200
3 February 2016 | By Victoria White
The FDA has granted the designation for maintenance therapy in subjects with platinum-sensitive advanced ovarian cancer...
Planning permission for first proton beam therapy clinic in England
3 February 2016 | By Victoria White
Proton Partners International have received formal planning permission to build the proton beam therapy clinic in Northumberland...
Head and neck cancer treatment market to reach $1.53b by 2024
3 February 2016 | By Victoria White
GlobalData says the treatment market for head and neck cancer will expand almost fourfold from $386 million in 2014 to $1.53 billion...
Celyad appoints new Vice-President of Global Regulatory Affairs
3 February 2016 | By Victoria White
Celyad has appointed Dr Richard Mountfield as Vice-President of Global Regulatory Affairs...
GSK submits sBLA seeking expanded indication for Flulaval Quadrivalent
3 February 2016 | By Victoria White
The submission seeks an expanded indication for Flulaval Quadrivalent in the US for children six months through 35 months of age...
EC approves osimertinib in EGFR T790M mutation-positive NSCLC
3 February 2016 | By Victoria White
The European Commission (EC) has granted conditional marketing authorisation for AstraZeneca's Tagrisso (AZD9291, osimertinib) for the treatment of adult patients with locally advanced or metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC).
Incentives and collaborations required to tackle superbugs, says GlobalData
2 February 2016 | By GlobalData
A GlobalData analyst says increased collaboration and further financial incentives are required to fight the mounting threat posed by superbugs...
